Skip to content.
Institutional Investors
Advisers / Individual Investors

Spotlight

Commercialising university research: insights from AlbionVC’s Dave Grimm

In this Infinite Frontiers conversation, AlbionVC Partner Dave Grimm explores why Europe lags in commercialising research, how deep tech spinouts can scale from lab to market, and what founders, investors and universities must do to build the next generation of breakthrough companies.

Read the article >
Why we invested in geoSurge

Why we invested in geoSurge

Read the article >

NHIM Part 2: How Anthropic, Mythos and AI Agents Are Rewriting Cybersecurity 

Read the article >
Why we invested in Flok Health

Why we invested in Flok Health

Read the article >
Why we partnered with Firenze

Why we partnered with Firenze

Read the article >

Why we invested in Kinfolk

Read the article >

Why we invested in Bound

Read the article >

Celebrating Innovation: The Harley Street HealthTech Pioneer Award

Read the article >

Our journey with Oviva from Seed to Series D

Read the article >
H2 2025 Market Recap: Venture Capital in Transition

H2 2025 Market Recap: Venture Capital in Transition

Read the article >

Transforming Focal Epilepsy Treatment: Our Investment in EpilepsyGTx

Read the article >

Why we invested in Fit Collective

Read the article >

Sign-up to know what’s next

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
I’m interested in…